Relief Therapeutics Holding AG (RLFTF)

[Vanilla Fitbit]

The Relief Agreement states that in the event Relief does not approve additional overages to the Initial Budget, NeuroRx shall be free to bring in other parties in order to complete the Relief Product study. The Relief Agreement further provides for Relief to fund the costs associated with the clinical development of the inhaled Relief Product in the United States in reliance upon NeuroRx’s agreement to conduct, manage, supervise and oversee its clinical development. Should Relief not fund the costs associated with the clinical development of the inhaled Relief Product in the United States, then NeuroRx shall have the freedom to bring a replacement investor.
210